Histamine H2 Blocking Drugs and the Risk for Alzheimer’s Disease: The Rotterdam Study
- 1 March 1997
- journal article
- Published by Elsevier in Neurobiology of Aging
- Vol. 18 (2) , 257-259
- https://doi.org/10.1016/s0197-4580(97)00010-9
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Do nonsteroidal anti-inflammatory drugs decrease the risk for Alzheimer's disease?Neurology, 1995
- Delayed onset of Alzheimer's disease with nonsteroidal anti-inflammatory and histamine H2 blocking drugsNeurobiology of Aging, 1995
- Prevalence of Alzheimer's disease and vascular dementia: association with education. The Rotterdam studyBMJ, 1995
- Excitotoxicity, free radicals, and cell membrane changesAnnals of Neurology, 1994
- Determinants of disease and disability in the elderly: The Rotterdam elderly studyEuropean Journal of Epidemiology, 1991
- CAMDEX: A Standardised Instrument for the Diagnosis of Mental Disorder in the Elderly with Special Reference to the Early Detection of DementiaThe British Journal of Psychiatry, 1986
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984
- The need for randomization in the study of intended effectsStatistics in Medicine, 1983
- A semi-structured clinical interview for the assessment of diagnosis and mental state in the elderly: the Geriatric Mental State Schedule: I. Development and reliabilityPsychological Medicine, 1976
- “Mini-mental state”Journal of Psychiatric Research, 1975